<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Insulin-like growth factor II (IGF-II) plays a key role in mammalian growth, influencing foetal cell division and differentiation and possibly metabolic regulation </plain></SENT>
<SENT sid="1" pm="."><plain>The mature 67 amino acid <z:chebi fb="7" ids="16670">peptide</z:chebi> shares sequence homology with both insulin and IGF-I </plain></SENT>
<SENT sid="2" pm="."><plain>The liver is the main <z:chebi fb="32" ids="24621">endocrine</z:chebi> source of IGFs, but autocrine/paracrine activity is found in most tissues </plain></SENT>
<SENT sid="3" pm="."><plain>The type 1 receptor mediates most of the biological effects of IGF-I and IGF-II; the type 2 receptor is involved with IGF-II degradation </plain></SENT>
<SENT sid="4" pm="."><plain>Binding proteins may both localise IGFs to the receptors and regulate their activities </plain></SENT>
<SENT sid="5" pm="."><plain>The IGF2 gene is maternally imprinted in mouse and human </plain></SENT>
<SENT sid="6" pm="."><plain>Relaxation of IGF2 imprinting occurs in the <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> of somatic <z:hpo ids='HP_0001548'>overgrowth</z:hpo>, <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumour</z:e> and a number of other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>In the general adult population, the IGF2-INS gene cluster may also influence body weight, in which case IGF-II function could become a target for therapeutic intervention in <z:hpo ids='HP_0001513'>obesity</z:hpo> </plain></SENT>
</text></document>